Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-014329
Filing Date
2024-12-30
Accepted
2024-12-30 14:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27714
2 filename2.txt TEXT-EXTRACT 1215
  Complete submission text file 0000000000-24-014329.txt   40278
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filed for) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-284022
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)